Cargando…
Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies
INTRODUCTION: Migraine is associated with substantial functional impairment and affects many aspects of daily life. METHODS: Using data from SAMURAI and SPARTAN (double-blind, placebo-controlled, phase 3 studies) and GLADIATOR (an open-label, phase 3 study enrolling patients who had completed SAMURA...
Autores principales: | Smith, Timothy, Krege, John H., Rathmann, Suchitrita S., Dowsett, Sherie A., Hake, Ann, Nery, Emel S. M., Matthews, Brandy R., Doty, Erin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606429/ https://www.ncbi.nlm.nih.gov/pubmed/32447545 http://dx.doi.org/10.1007/s40120-020-00185-5 |
Ejemplares similares
-
Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks
por: Tepper, Stewart J., et al.
Publicado: (2020) -
Safety findings from Phase 3 lasmiditan studies for acute treatment
of migraine: Results from SAMURAI and SPARTAN
por: Krege, John H, et al.
Publicado: (2019) -
Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study
por: Ashina, Messoud, et al.
Publicado: (2021) -
Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine
por: Doty, Erin Gautier, et al.
Publicado: (2019) -
Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine
por: Tassorelli, C, et al.
Publicado: (2021)